Top Markets
#1 Black Phoenix Black Phoenix +361.13%
#2 Islamic Coin Islamic Coin +158.08%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +56.60%
#5 Akedo Akedo +45.03%
#6 BasedHype BasedHype +32.41%
#7 Acurast Acurast +26.37%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.69%
#10 Playnance Playnance +18.61%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Classifica tra le azioni #41147
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Prezzo delle azioni
$0.04082105
Ultima sincronizzazione: 2024-08-12
Capitalizzazione di mercato
$39.09K
Variazione (1 giorno)
-19.83%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Destiny Pharma plc (DEST)

Categoria

Healthcare
Rapporto P/B per Destiny Pharma plc (DEST)
Rapporto P/B al August 2026 TTM: 0.30
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Destiny Pharma plc, il rapporto P/B attuale (TTM) è 0.30. Alla fine del 2022, era pari a 4.92.
Storico del rapporto P/B per Destiny Pharma plc da 2013 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 0.30 -95.72%
2023 6.91 40.25%
2022 4.92 -41.17%
2021 8.37 236.00%
2020 2.49 2.62%
2019 2.43 10.15%
2018 2.20 -24.15%
2017 2.91 -95.05%
2016 58.67 -16.78%
2015 70.51 53.43%
2014 45.96 -73.27%
2013 171.94 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 2,015.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 2,044.70%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 1,127.70%
BE